4.5 Article

Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons

Journal

HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 18, Issue 5, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2022.2075211

Keywords

Influenza; vaccination; coverage; China; Shanghai

Funding

  1. Shanghai Municipal Health Commission [GWV-10.2-YQ41]
  2. Science and Technology Commission of Shanghai Municipality, China [20JC1410200]

Ask authors/readers for more resources

This study investigated the coverage and trends of influenza vaccination in Shanghai, finding that the vaccination rate is relatively low in all subgroups of the population. Therefore, measures need to be taken to promote influenza vaccination in Shanghai.
Influenza is a common infectious disease resulting in substantial morbidity and mortality globally. The most effective strategy for preventing influenza is annual vaccination; however, the coverage rate of the influenza vaccine in Shanghai has not been well explored or reported. Therefore, this study aimed to determine coverage with the influenza vaccine and access trends in Shanghai city; data from Shanghai immunization information system was analyzed to estimate vaccination coverage during 2016-2017 through 2020-2021 influenza seasons. Vaccination coverage by age groups, immigration status, and districts was accessed. The influenza vaccination coverage (at least one dose) for 2016/2017 to 2020/2021 influenza seasons was 10.8% (95% CI: 10.7-10.8), 12.3% (95% CI: 12.3-12.4), 10.1% (95% CI: 10.0-10.1), 20.1% (95% CI: 20.0-20.2) and 50.8% (95% CI: 50.7-50.8) respectively. Although we found significantly higher vaccination coverage in females, children from 6 months to 17 years, and residents, it is still low in all subgroups of the population in Shanghai. Therefore, taking effective steps to promote influenza vaccination in Shanghai is recommended.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available